- £172.60m
- £166.59m
- £38.44m
Full Year 2025 Trading Update
PDMR Shareholding/SIP & Total Voting Rights
PDMR Shareholding/Share Incentive Plan and TVR
Brief: Diaceutics H1 Pretax Profit GBP -3.013 Million
H1 2025 Results
Notice of Results
Holding(s) in Company
PDMR Shareholding/Share Incentive Plan and TVR
Holding(s) in Company
Diaceutics at Canaccord Genuity Growth Conference
Diaceutics Announces Key Leadership Appointment
Holding(s) in Company
Issue of Share Options / PDMR Shareholdings
Brief: Diaceutics Reports 22% Revenue Growth To £14.6 Mln In HY
22% Revenue Growth H125 representing 3-yr CAGR 25%
Expansion of PMx Commercialization Partnership
Notice of AGM and Posting of Annual Report
Transaction by Persons Closely Associated to PDMRs
Brief: Diaceutics Says Do Not Expect Direct Impact From Recent Tariff Announcements